Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Intergroupe Francophone de Cancérologie Thoracique | Researchclopedia

Back to institutions

Intergroupe Francophone de Cancérologie Thoracique

Parisother

453

Works

33,666

Citations

74

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies

Top Researchers

Fabrice Barlési Institut Gustave Roussy

1,472 works71,225 citationsh-index: 99

Recent Research

545P Real world data of capecitabine plus gemcitabine in thymic epithelial tumors: A retrospective analysis

Daniela Miliziano,A. Lopez Gutierrez,et al.

20260 citations

Cancer Immunotherapy and Biomarkers

Colorectal Cancer Treatments and Studies

Occupational and environmental lung diseases

Cancer Genomics and Diagnostics

Radiomics and Machine Learning in Medical Imaging

Pleural and Pulmonary Diseases

Gastric Cancer Management and Outcomes

Myasthenia Gravis and Thymoma

Chronic Myeloid Leukemia Treatments

Benjamin Besse Inserm

1,838 works55,594 citationsh-index: 100

Élisabeth Brambilla Centre National de la Recherche Scientifique

502 works49,211 citationsh-index: 102

Jean‐Pierre Pignon Inserm

482 works48,323 citationsh-index: 95

Julien Mazières Université Fédérale de Toulouse Midi-Pyrénées

991 works48,291 citationsh-index: 91

François Guilhot Inserm

625 works42,802 citationsh-index: 84

Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial

Thomas Walter,Julien Mazieres,et al.

20260 citations

Club cell secretory protein (CCSP) serum concentration is a prognostic factor after surgical resection of localized non-small cell lung cancer in patients in the IFCT-0302 trial

Solenn Brosseau,Harry Etienne,et al.

20260 citations

Abstract PS5-07-12: Opt-pembro: a phase III randomized trial of adjuvant pembrolizumab omission in patients with early-stage triple-negative breast cancer achieving pathologic complete response after neoadjuvant chemo-immunotherapy

J. M. Ribeiro,F. Duhoux,et al.

20260 citations

Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 “DICIPLE” Phase III Trial

G. Zalcman,A. Madroszyk,et al.

20261 citations

Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results

Delphine Rea,Slawomira Kyrcz-Krzemien,et al.

20260 citations